Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2023, 167(2):99-108 | DOI: 10.5507/bp.2023.008

Current causes of mesothelioma: how has the asbestos ban changed the perspective?

Magdalena Janosikova, Marie Nakladalova, Ladislav Stepanek
Department of Occupational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, I. P. Pavlova 185/6, 779 00 Olomouc, Czech Republic

The association of mesothelioma, a lethal lung disease, with asbestos has led to an absolute ban on asbestos in at least 55 countries worldwide. The purpose of this paper is to review residual exposure to asbestos as well as other emerging causes of mesothelioma outside asbestos. The review provides detailed description of asbestos minerals, their geographical locations, mesothelioma in these areas, as well as contemporary possible sources of asbestos exposure. Second, we examine other emerging causes of mesothelioma including: ionizing radiation as the second most important risk factor after asbestos, particularly relevant to patients undergoing radiotherapy, third, carbon nanotubes which are under investigation and fourth, Simian virus 40. In the case of asbestos per se, the greatest risk is from occupational exposure during mining and subsequent processing. Of the non-occupational exposures, environmental exposure is most serious, followed by exposure from indoor asbestos minerals and secondary familial exposure. Overall, asbestos is still a major risk factor, but alternative causes should not be neglected, especially in young people, in women and those with a history of radiotherapy or living in high-risk locations.

Keywords: mesothelioma, asbestos, non-asbestos etiology, occupational exposure, non-occupational exposure

Received: December 27, 2022; Revised: February 4, 2023; Accepted: February 9, 2023; Prepublished online: February 20, 2023; Published: June 12, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Janosikova, M., Nakladalova, M., & Stepanek, L. (2023). Current causes of mesothelioma: how has the asbestos ban changed the perspective? Biomedical papers, 167(2), 99-108. doi: 10.5507/bp.2023.008
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Neumann V, Löseke S, Nowak D, Herth FJ, Tannapfel A. Malignant pleural mesothelioma: incidence, etiology, diagnosis, treatment, and occupational health. Dtsch Arztebl Int 2013;110(18):319-26. Go to original source... Go to PubMed...
    2. Tischoff I, Neid M, Neumann V, Tannapfel A. Pathohistological diagnosis and differential diagnosis. Recent Results Cancer Res 2011;189:57-78. Go to original source... Go to PubMed...
    3. Beasley MB, Galateau-Salle F, Dacic S. Pleural mesothelioma classification update. Virchows Arch 2021;478(1):59-72. Go to original source... Go to PubMed...
    4. Mesothelioma Fact Sheet. Cancer Today. 2020 [cited 2022 Sep 21]; Available from: https://gco.iarc.fr/today/fact-sheets-cancers.
    5. Carbone M, Adusumilli PS, Alexander HR Jr, Baas P, Bardelli F, Bononi A, Bueno R, Felley-Bosco E, Galateau-Salle F, Jablons D, Mansfield AS, Minaai M, de Perrot M, Pesavento P, Rusch V, Severson DT, Taioli E, Tsao A, Woodard G, Yang H, Zauderer MG, Pass HI. Mesothelioma: Scientific clues for prevention, diagnosis, and therapy [published correction appears in CA Cancer J Clin 2020 Jul;70(4):313-314]. CA Cancer J Clin 2019;69(5):402-29. Go to original source... Go to PubMed...
    6. Tischoff I, Tannapfel A. Mesotheliom [Mesothelioma]. Pathologe 2017;38(6):547-60. Go to original source... Go to PubMed...
    7. Attanoos RL, Churg A, Galateau-Salle F, Gibbs AR, Roggli VL. Malignant Mesothelioma and Its Non-Asbestos Causes. Arch Pathol Lab Med 2018;142(6):753-60. Go to original source... Go to PubMed...
    8. Gandhi M, Nair S. New vistas in malignant mesothelioma: MicroRNA architecture and NRF2/MAPK signal transduction. Life Sci 2020;257:118123. Go to original source... Go to PubMed...
    9. Opitz I. Management of malignant pleural mesothelioma-The European experience. J Thorac Dis 2014;6 Suppl 2(Suppl 2):S238-S52.
    10. Case BW, Abraham JL, Meeker G, Pooley FD, Pinkerton KE. Applying definitions of "asbestos" to environmental and "low-dose" exposure levels and health effects, particularly malignant mesothelioma. J Toxicol Environ Health B Crit Rev 2011;14(1-4):3-39. Go to original source... Go to PubMed...
    11. ISO 10312:2019(en): Ambient air - Determination of asbestos fibres - Direct transfer transmission electron microscopy method. ISO Online Browsing Platform. 2019 [cited 2022 Sep 21]; Available from: https://www.iso.org/obp/ui/#iso:std:iso:10312:ed-2:v1:en.
    12. Asbestos: Geology, Mineralogy, Mining, and Uses. Asbestos Statistics and Information. 2022 [cited 2022 Sep 21]; Available from: https://pubs.usgs.gov/of/2002/of02-149/.
    13. Solbes E, Harper RW. Biological responses to asbestos inhalation and pathogenesis of asbestos-related benign and malignant disease. J Investig Med 2018;66(4):721-27. Go to original source... Go to PubMed...
    14. Furuya S, Chimed-Ochir O, Takahashi K, David A, Takala J. Global Asbestos Disaster. Int J Environ Res Public Health 2018;15(5):1000. Go to original source... Go to PubMed...
    15. Stayner L, Welch LS, Lemen R. The worldwide pandemic of asbestos-related diseases. Annu Rev Public Health 2013;34:205-16. Go to original source... Go to PubMed...
    16. Pira E, Donato F, Maida L, Discalzi G. Exposure to asbestos: past, present and future. J Thorac Dis 2018;10(Suppl 2):S237-S45. Go to original source... Go to PubMed...
    17. ASBESTOS: Mineral Commodity Summaries. Asbestos Statistics and Information. 2022 [cited 2022 Sep 21]; Available from: https://pubs.usgs.gov/periodicals/mcs2021/mcs2021-asbestos.pdf; Asbestos (usgs.gov).
    18. Current Asbestos Bans. International Ban Asbestos Secretariat. 2022 [cited 2022 Sep 21]; Available from: http://ibasecretariat.org/alpha_ban_list.php.
    19. Brook MS, Black PM, Salmond J, Dirks KN, Berry TA, Steinhorn G. Erionite in Auckland bedrock and malignant mesothelioma: an emerging public and occupational health hazard? N Z Med J 2020;133(1518):73-78.
    20. Goldberg M, Luce D. The health impact of nonoccupational exposure to asbestos: what do we know? Eur J Cancer Prev 2009;18(6):489-503. Go to original source... Go to PubMed...
    21. Patel JP, Brook MS. Erionite asbestiform fibres and health risk in Aotearoa/New Zealand: A research note. N Z Geog 2021;77(2),123-9. Go to original source...
    22. Carbone M, Baris YI, Bertino P, Brass B, Comertpay S, Dogan AU, Gaudino G, Jube S, Kanodia S, Partridge CR, Pass HI, Rivera ZS, Steele I, Tuncer M, Way S, Yang H, Miller A. Erionite exposure in North Dakota and Turkish villages with mesothelioma. Proc Natl Acad Sci U S A 2011;108(33):13618-23. Go to original source... Go to PubMed...
    23. Arsenic, metals, fibres, and dusts. In IARC Monographs: Volume 100 C A review of human carcinogens. International Agency for Research on Cancer. 2009 [cited 2022 Sep 21]; (pp. 219 - 315). Available from: https://monographs.iarc.who.int/wp-content/uploads/2018/06/mono100C.pdf
    24. Some Nanomaterials and Some Fibres: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 111. International Agency for Research on Cancer. 2014 [cited 2022 Sep 21]; Available from: https://publications.iarc.fr/Book-And-Report-Series/Iarc-Monographs-On-The-Identification-Of-Carcinogenic-Hazards-To-Humans/Some-Nanomaterials-And-Some-Fibres-2017
    25. List of classifications by cancer sites with sufficient or limited evidence in humans: IARC Monographs Volumes 1-132a. IARC MONOGRAPHS ON THE IDENTIFICATION OF CARCINOGENIC HAZARDS TO HUMANS. 2022 [cited 2022 Sep 21]; Available from: https://monographs.iarc.who.int/wp-content/uploads/2019/07/Classifications_by_cancer_site.pdf
    26. Emri SA. The Cappadocia mesothelioma epidemic: its influence in Turkey and abroad. Ann Transl Med 2017;5(11):239. Go to original source... Go to PubMed...
    27. Filetti V, Vitale E, Broggi G, Hagnäs MP, Candido S, Spina A, Lombardo C. Update of in vitro, in vivo and ex vivo fluoro-edenite effects on malignant mesothelioma: A systematic review (Review). Biomed Rep 2020;13(6):60. Go to original source... Go to PubMed...
    28. Emri S, Demir A, Dogan M, Akay H, Bozkurt B, Carbone M, Baris I. Lung diseases due to environmental exposures to erionite and asbestos in Turkey. Toxicol Lett 2002;127(1-3):251-7. Go to original source... Go to PubMed...
    29. McDonald JC, McDonald AD. The epidemiology of mesothelioma in historical context. Eur Respir J 1996;9(9):1932-42. Go to original source... Go to PubMed...
    30. Matanoski GM, Tonascia JA, Correa-Villaseñor A, Yates KC, Fink N, Elliott E, Sanders B, Lantry D. Cancer risks and low-level radiation in U.S. shipyard workers. J Radiat Res 2008;49(1):83-91. Go to original source... Go to PubMed...
    31. Goodman JE, Nascarella MA, Valberg PA. Ionizing radiation: a risk factor for mesothelioma. Cancer Causes Control 2009;20(8):1237-54. Go to original source... Go to PubMed...
    32. Visci G, Rizzello E, Zunarelli C, Violante FS, Boffetta P. Relationship between exposure to ionizing radiation and mesothelioma risk: A systematic review of the scientific literature and meta-analysis. Cancer Med 2022;11(3):778-89. Go to original source... Go to PubMed...
    33. Mizuki M, Yukishige K, Abe Y, Tsuda T. A case of malignant pleural mesothelioma following exposure to atomic radiation in Nagasaki. Respirology 1997;2(3):201-05. Go to original source... Go to PubMed...
    34. Farioli A, Violante FS, Mattioli S, Curti S, Kriebel D. Risk of mesothelioma following external beam radiotherapy for prostate cancer: a cohort analysis of SEER database. Cancer Causes Control 2013;24(8):1535-45. Go to original source... Go to PubMed...
    35. Chang ET, Lau EC, Mowat FS, Teta MJ. Therapeutic radiation for lymphoma and risk of second primary malignant mesothelioma. Cancer Causes Control 2017;28(9):971-79. Go to original source... Go to PubMed...
    36. De Bruin ML, Burgers JA, Baas P, van 't Veer MB, Noordijk EM, Louwman MW, Zijlstra JM, van den Berg H, Aleman BM, van Leeuwen FE. Malignant mesothelioma after radiation treatment for Hodgkin lymphoma. Blood 2009;113(16):3679-81. Go to original source... Go to PubMed...
    37. Farioli A, Ottone M, Morganti AG, Compagnone G, Romani F, Cammelli S, Mattioli S, Violante FS. Radiation-induced mesothelioma among long-term solid cancer survivors: a longitudinal analysis of SEER database. Cancer Med 2016;5(5):950-59. Go to original source... Go to PubMed...
    38. Metz-Flamant C, Guseva Canu I, Laurier D. Malignant pleural mesothelioma risk among nuclear workers: a review. J Radiol Prot 2011;31(1):9-23. Go to original source... Go to PubMed...
    39. Mumma MT, Sirko JL, Boice JD Jr, Blot WJ. Mesothelioma mortality within two radiation monitored occupational cohorts. Int J Radiat Biol 2022;98(4):786-94. Go to original source... Go to PubMed...
    40. Gibb H, Fulcher K, Nagarajan S, McCord S, Fallahian NA, Hoffman HJ, Haver C, Tolmachev S. Analyses of radiation and mesothelioma in the US Transuranium and Uranium Registries. Am J Public Health 2013;103(4):710-16. Go to original source... Go to PubMed...
    41. Dong J, Ma Q. Integration of inflammation, fibrosis, and cancer induced by carbon nanotubes. Nanotoxicology 2019;13(9):1244-74. Go to original source... Go to PubMed...
    42. Kane AB, Hurt RH, Gao H. The asbestos-carbon nanotube analogy: An update. Toxicol Appl Pharmacol 2018;361:68-80. Go to original source... Go to PubMed...
    43. Kim JS, Song KS, Lee JK, Choi YC, Bang IS, Kang CS, Yu IJ. Toxicogenomic comparison of multi-wall carbon nanotubes (MWCNTs) and asbestos. Arch Toxicol 2012;86(4):553-62. Go to original source... Go to PubMed...
    44. Rittinghausen S, Hackbarth A, Creutzenberg O, Ernst H, Heinrich U, Leonhardt A, Schaudien D. The carcinogenic effect of various multi-walled carbon nanotubes (MWCNTs) after intraperitoneal injection in rats. Part Fibre Toxicol 2014;11:59. Go to original source... Go to PubMed...
    45. Takagi A, Hirose A, Futakuchi M, Tsuda H, Kanno J. Dose-dependent mesothelioma induction by intraperitoneal administration of multi-wall carbon nanotubes in p53 heterozygous mice. Cancer Sci 2012;103(8):1440-4. Go to original source...
    46. Fukushima S, Kasai T, Umeda Y, Ohnishi M, Sasaki T, Matsumoto M. Carcinogenicity of multi-walled carbon nanotubes: challenging issue on hazard assessment. J Occup Health 2018;60(1):10-30. Go to original source... Go to PubMed...
    47. Orsi M, Al Hatem C, Leinardi R, Huaux F. Carbon nanotubes under scrutiny: Their toxicity and utility in mesothelioma research. Appl Sci 2020;10.13:4513. Go to original source...
    48. Grosse Y, Loomis D, Guyton KZ, Lauby-Secretan B, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Scoccianti C, Mattock H, Straif K. Carcinogenicity of fluoro-edenite, silicon carbide fibres and whiskers, and carbon nanotubes. Lancet Oncol 2014;15(13):1427-28. Go to original source... Go to PubMed...
    49. Kuempel ED, Jaurand MC, Møller P, Morimoto Y, Kobayashi N, Pinkerton KE, Sargent LM, Vermeulen RC, Fubini B, Kane AB. Evaluating the mechanistic evidence and key data gaps in assessing the potential carcinogenicity of carbon nanotubes and nanofibers in humans. Crit Rev Toxicol 2017;47(1):1-58. Go to original source... Go to PubMed...
    50. Price MJ, Darnton AJ, McElvenny DM, Hodgson JT. Simian virus 40 and mesothelioma in Great Britain. Occup Med (Lond) 2007;57(8):564-68. Go to original source... Go to PubMed...
    51. Vilchez RA, Kozinetz CA, Arrington AS, Madden CR, Butel JS. Simian virus 40 in human cancers. Am J Med 2003;114(8):675-84. Go to original source... Go to PubMed...
    52. Procopio A, Strizzi L, Vianale G, Betta P, Puntoni R, Fontana V, Tassi G, Gareri F, Mutti L. Simian virus-40 sequences are a negative prognostic cofactor in patients with malignant pleural mesothelioma. Genes Chromosomes Cancer 2000;29(2):173-79. Go to original source...
    53. Carbone M, Gazdar A, Butel JS. SV40 and human mesothelioma. Transl Lung Cancer Res 2020;9(Suppl 1):S47-S59. Go to original source... Go to PubMed...
    54. Agents Classified by the IARC Monographs, Volumes 1-123. IARC Monographs on the identification of carcinogenic hazards to humans. 2018 [cited 2022 Sep 23]; Available from: https://monographs.iarc.who.int/wp-content/uploads/2018/09/ClassificationsAlphaOrder.pdf
    55. Ji J, Sundquist J, Sundquist K. Incidence and familial risk of pleural mesothelioma in Sweden: a national cohort study. Eur Respir J 2016;48(3):873-79. Go to original source... Go to PubMed...
    56. Tunesi S, Ferrante D, Mirabelli D, Andorno S, Betti M, Fiorito G, Guarrera S, Casalone E, Neri M, Ugolini D, Bonassi S, Matullo G, Dianzani I, Magnani C. Gene-asbestos interaction in malignant pleural mesothelioma susceptibility. Carcinogenesis 2015;36(10):1129-35. Go to original source... Go to PubMed...
    57. Betti M, Aspesi A, Ferrante D, Sculco M, Righi L, Mirabelli D, Napoli F, Rondón-Lagos M, Casalone E, Vignolo Lutati F, Ogliara P, Bironzo P, Gironi CL, Savoia P, Maffè A, Ungari S, Grosso F, Libener R, Boldorini R, Valiante M, Pasini B, Matullo G, Scagliotti G, Magnani C, Dianzani I. Sensitivity to asbestos is increased in patients with mesothelioma and pathogenic germline variants in BAP1 or other DNA repair genes. Genes Chromosomes Cancer 2018;57(11):573-83. Go to original source... Go to PubMed...
    58. Franko A, Kotnik N, Goricar K, Kovac V, Dodic-Fikfak M, Dolzan V. The Influence of Genetic Variability on the Risk of Developing Malignant Mesothelioma. Radiol Oncol 2018;52(1):105-11. Go to original source... Go to PubMed...
    59. Napolitano A, Pellegrini L, Dey A, Larson D, Tanji M, Flores EG, Kendrick B, Lapid D, Powers A, Kanodia S, Pastorino S, Pass HI, Dixit V, Yang H, Carbone M. Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma. Oncogene 2016;35(15):1996-2002. Go to original source... Go to PubMed...
    60. Piber P, Vavpetic N, Goricar K, Dolzan V, Kovac V, Franko A. The influence of genetic variability in IL1B and MIR146A on the risk of pleural plaques and malignant mesothelioma. Radiol Oncol 2020;54(4):429-36. Go to original source... Go to PubMed...
    61. Panou V, Gadiraju M, Wolin A, Weipert CM, Skarda E, Husain AN, Patel JD, Rose B, Zhang SR, Weatherly M, Nelakuditi V, Knight Johnson A, Helgeson M, Fischer D, Desai A, Sulai N, Ritterhouse L, Røe OD, Turaga KK, Huo D, Segal J, Kadri S, Li Z, Kindler HL, Churpek JE. Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma. J Clin Oncol 2018;36(28):2863-71. Go to original source... Go to PubMed...
    62. Wagner JC, Sleggs CA, Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med 1960;17(4):260-71. Go to original source... Go to PubMed...
    63. Murray R. Asbestos: a chronology of its origins and health effects. Br J Ind Med 1990;47(6):361-65. Go to original source... Go to PubMed...
    64. Lilienfeld DE. The silence: the asbestos industry and early occupational cancer research-a case study. Am J Public Health 1991;81(6):791-800. Go to original source... Go to PubMed...
    65. Hashim D, Boffetta P. Occupational and environmental exposures and cancers in developing countries. Ann Glob Health 2014;80(5):393-411. Go to original source... Go to PubMed...
    66. Occupational Asbestos Exposure. The Mesothelioma Center. 2022 [cited 2022 Sep 22]; Available from: https://www.asbestos.com/occupations/.
    67. Reid A, de Klerk NH, Magnani C, Ferrante D, Berry G, Musk AW, Merler E. Mesothelioma risk after 40 years since first exposure to asbestos: a pooled analysis. Thorax 2014;69(9):843-50. Go to original source... Go to PubMed...
    68. Ferrante D, Mirabelli D, Silvestri S, Azzolina D, Giovannini A, Tribaudino P, Magnani C. Mortality and mesothelioma incidence among chrysotile asbestos miners in Balangero, Italy: A cohort study. Am J Ind Med 2020;63(2):135-45. Go to original source... Go to PubMed...
    69. Wilczyńska U, Szymczak W, Szeszenia-Dabrowska N. Mortality from malignant neoplasms among workers of an asbestos processing plant in Poland: results of prolonged observation. Int J Occup Med Environ Health 2005;18(4):313-26. Go to PubMed...
    70. ¦wi±tkowska B, Szeszenia-D±browska N. Mesothelioma continues to increase even 40 years after exposure - Evidence from long-term epidemiological observation. Lung Cancer 2017;108:121-25. Go to original source... Go to PubMed...
    71. Williams PR, Phelka AD, Paustenbach DJ. A review of historical exposures to asbestos among skilled craftsmen (1940-2006). J Toxicol Environ Health B Crit Rev 2007;10(5):319-77. Go to original source... Go to PubMed...
    72. Koskinen K, Pukkala E, Martikainen R, Reijula K, Karjalainen A. Different measures of asbestos exposure in estimating risk of lung cancer and mesothelioma among construction workers. J Occup Environ Med 2002;44(12):1190-96. Go to original source... Go to PubMed...
    73. Cohen HJ, Van Orden DR. Asbestos exposures of mechanics performing clutch service on motor vehicles. J Occup Environ Hyg 2008;5(3):148-56. Go to original source... Go to PubMed...
    74. Neitzel RL, Sayler SK, Demond AH, d'Arcy H, Garabrant DH, Franzblau A. Measurement of asbestos emissions associated with demolition of abandoned residential dwellings. Sci Total Environ 2020;722:137891. Go to original source... Go to PubMed...
    75. Harding AH, Darnton AJ. Asbestosis and mesothelioma among British asbestos workers (1971-2005). Am J Ind Med 2010;53(11):1070-80. Go to original source... Go to PubMed...
    76. Rake C, Gilham C, Hatch J, Darnton A, Hodgson J, Peto J. Occupational, domestic and environmental mesothelioma risks in the British population: a case-control study. Br J Cancer 2009;100(7):1175-83. Go to original source... Go to PubMed...
    77. Muscat JE, Wynder EL. Cigarette smoking, asbestos exposure, and malignant mesothelioma. Cancer Res 1991;51(9):2263-67.
    78. Corfiati M, Scarselli A, Binazzi A, Di Marzio D, Verardo M, Mirabelli D, Gennaro V, Mensi C, Schallemberg G, Merler E, Negro C, Romanelli A, Chellini E, Silvestri S, Cocchioni M, Pascucci C, Stracci F, Romeo E, Trafficante L, Angelillo I, Menegozzo S, Musti M, Cavone D, Cauzillo G, Tallarigo F, Tumino R, Melis M, Iavicoli S, Marinaccio A. Epidemiological patterns of asbestos exposure and spatial clusters of incident cases of malignant mesothelioma from the Italian national registry. BMC Cancer 2015;15:286. Go to original source... Go to PubMed...
    79. Mensi C, Macchione M, Termine L, Canti Z, Rivolta G, Riboldi L, Chiappino G. Esposizioni professionali nel settore tessile non-amianto in Lombardia: i dati del Registro Regionale [Asbestos exposure in the non-asbestos textile industry: the experience of the Lombardy Mesothelioma Registry]. Epidemiol Prev 2007;31(4 Suppl 1):27-30.
    80. Yu IJ, Choi JK, Kang SK, Chang HK, Chung YH, Han JH, Song KS, Lee YM, Chung HK. Potential source of asbestos in non-asbestos textile manufacturing company. Environ Int 2002;28(1-2):35-39. Go to original source... Go to PubMed...
    81. Barbieri PG, Somigliana A, Lombardi S, Girelli R, Rocco A, Pezzotti C, Silvestri S. Riciclaggio di sacchi di juta, patologie asbesto-correlate ed esposizione ad amianto in agricoltura [Recycle of jute bags; asbestos in agriculture, exposure and pathology ]. G Ital Med Lav Ergon 2008;30(4):329-33.
    82. Bianchi C, Bianchi T, Ramani L. Mesotelioma maligno della pleura nella donna [Malignant mesothelioma of the pleura among women]. Med Lav 2004;95(5):376-80. Go to PubMed...
    83. Emri S, Demir A, Dogan M, Akay H, Bozkurt B, Carbone M, Baris I. Lung diseases due to environmental exposures to erionite and asbestos in Turkey. Toxicol Lett 2002;127(1-3):251-57. Go to original source... Go to PubMed...
    84. Pan XL, Day HW, Wang W, Beckett LA, Schenker MB. Residential proximity to naturally occurring asbestos and mesothelioma risk in California. Am J Respir Crit Care Med 2005;172(8):1019-25. Go to original source... Go to PubMed...
    85. Sakellariou K, Malamou-Mitsi V, Haritou A, Koumpaniou C, Stachouli C, Dimoliatis ID, Constantopoulos SH. Malignant pleural mesothelioma from nonoccupational asbestos exposure in Metsovo (north-west Greece): slow end of an epidemic? Eur Respir J 1996;9(6):1206-10. Go to original source... Go to PubMed...
    86. Bloise A, Catalano M, Critelli T, Apollaro C, Miriello D. Naturally occurring asbestos: potential for human exposure, san Severino Lucano (Basilicata, southern Italy). Environmental Earth Sciences 2017;76.19:1-13. Go to original source...
    87. Hendrickx M. Naturally occurring asbestos in eastern Australia: a review of geological occurrence, disturbance and mesothelioma risk. Env Geol 2009;57.4:909-26. Go to original source...
    88. Goldberg M, Luce D. The health impact of nonoccupational exposure to asbestos: what do we know? Eur J Cancer Prev 2009;18(6):489-503. Go to original source... Go to PubMed...
    89. Noonan CW. Environmental asbestos exposure and risk of mesothelioma. Ann Transl Med 2017;5(11):234. Go to original source... Go to PubMed...
    90. Bourdès V, Boffetta P, Pisani P. Environmental exposure to asbestos and risk of pleural mesothelioma: review and meta-analysis. Eur J Epidemiol 2000;16(5):411-17. Go to original source... Go to PubMed...
    91. Pan XL, Day HW, Wang W, Beckett LA, Schenker MB. Residential proximity to naturally occurring asbestos and mesothelioma risk in California. Am J Respir Crit Care Med 2005;172(8):1019-25. Go to original source... Go to PubMed...
    92. Airoldi C, Magnani C, Lazzarato F, Mirabelli D, Tunesi S, Ferrante D. Environmental asbestos exposure and clustering of malignant mesothelioma in community: a spatial analysis in a population-based case-control study. Environ Health 2021;20(1):103. Go to original source... Go to PubMed...
    93. Marinaccio A, Binazzi A, Bonafede M, Corfiati M, Di Marzio D, Scarselli A, Verardo M, Mirabelli D, Gennaro V, Mensi C, Schallemberg G, Merler E, Negro C, Romanelli A, Chellini E, Silvestri S, Cocchioni M, Pascucci C, Stracci F, Ascoli V, Trafficante L, Angelillo I, Musti M, Cavone D, Cauzillo G, Tallarigo F, Tumino R, Melis M. Malignant mesothelioma due to non-occupational asbestos exposure from the Italian national surveillance system (ReNaM): epidemiology and public health issues. Occup Environ Med 2015;72(9):648-55. Go to original source... Go to PubMed...
    94. Goswami E, Craven V, Dahlstrom DL, Alexander D, Mowat F. Domestic asbestos exposure: a review of epidemiologic and exposure data. Int J Environ Res Public Health 2013;10(11):5629-70. Go to original source... Go to PubMed...
    95. Sahmel J, Barlow CA, Gaffney S, Avens HJ, Madl AK, Henshaw J, Unice K, Galbraith D, DeRose G, Lee RJ, Van Orden D, Sanchez M, Zock M, Paustenbach DJ. Airborne asbestos take-home exposures during handling of chrysotile-contaminated clothing following simulated full shift workplace exposures. J Expo Sci Environ Epidemiol 2016;26(1):48-62. Go to original source... Go to PubMed...
    96. Magnani C, Agudo A, Gonzįlez CA, Andrion A, Calleja A, Chellini E, Dalmasso P, Escolar A, Hernandez S, Ivaldi C, Mirabelli D, Ramirez J, Turuguet D, Usel M, Terracini B. Multicentric study on malignant pleural mesothelioma and non-occupational exposure to asbestos. Br J Cancer 2000;83(1):104-11. Go to original source... Go to PubMed...
    97. Xu R, Barg FK, Emmett EA, Wiebe DJ, Hwang WT. Association between mesothelioma and non-occupational asbestos exposure: systematic review and meta-analysis. Environ Health 2018;17(1):90. Go to original source... Go to PubMed...
    98. Corn M, Crump K, Farrar DB, Lee RJ, McFee DR. Airborne concentrations of asbestos in 71 school buildings. Regul Toxicol Pharmacol 1991;13(1):99-114. Go to original source... Go to PubMed...
    99. Marsh GM, Riordan AS, Keeton KA, Benson SM. Non-occupational exposure to asbestos and risk of pleural mesothelioma: review and meta-analysis. Occup Environ Med 2017;74(11):838-46. Go to original source... Go to PubMed...

    This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content